BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rapamycin
,
rs7903146
,
KLK3
,
calcium channel activity
,
Allergy to pollen
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
N Myc
Summary
General Info
Curated Studies
Most Correlated Studies
Mouse c-myc N-myc deficient LT-HSCs and progenitor cells
Whole cochlea from E15 N-MYC knockout mouse embryos
Neuroblastoma cell line TET21N expressing N-MYC with or without MONDOA siRNA
Inhibition of Notch signaling in T-cell response
Breast tumors and hyperplasias from mice expressing N-terminally truncated β-catenin
Explore Curated Studies Results
Literature
Most Relevant Literature
Default Mode Network Modulation by Psychedelics: A Systematic Review.
Neural signatures of default mode network in major depression disorder after electroconvulsive thera…
The relationship between the default mode network and the theory of mind network as revealed by psyc…
Resting-state global brain activity affects early β-amyloid accumulation in default mode network.
MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
Dose-adjusted EPOCH-R in MYC Positive DLBCL
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients …
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ